Pirouette Medical

In honor of Flag Day, we have hoisted the Red White and Blue! Proudly manufacturing devices in our Portsmouth, NH facility! The flag now hangs above our newly minted Cleanroom. A perfect fit!

Exciting news! The response to Pirouette’s community round on Wefunder has been incredible and we have now officially raised over $1,000,000! This also brings us to $5M+ raised in total this round. If you’ve been considering investing or sharing our campaign, now is the time. Our round is filling up quickly. Learn more at wefunder.com/pirouette Safar Partners Gaingels Joseph M. Nemmers Jr. Y Combinator KINGSCROWD Capital Liquid 2 Ventures

It’s an exciting time here at Pirouette HQ! We just received a Notice of Award from the NIH – they have awarded us an administrative supplement of $97K+ to expand the scope of our Phase I award! 💸🔬 The Phase I award has been crucial in affirming the technical merit and commercial potential of our Naloxone HCl auto-injector. With this expanding scope, we can accelerate our progress toward FDA approval and commercialization, bringing us closer to saving lives. 🙌 NIH SEED https://lnkd.in/epgze9eF

Thanks to Olivia Strobl for putting together some company overview slides for KINGSCROWD's Demo Day, tomorrow at 12pm ET! Take a swipe through our presenting company details and consider joining us tomorrow with the link below 👇 Register: https://lnkd.in/e4UpGHZv

Join us at BIO 2024, June 3-6 in San Diego, where will be showcasing our innovative auto-injector aimed at revolutionizing the end-user and patient experience when administering an injection. Come see how we're reimagining injections. Find us at Booth 825 - the NIH SEED Innovation Zone. See you there! #BIO2024 

More Great News from BIO 2024! 🌟 We’re excited to announce that we have been invited to present for a second time at the BIO conference, this time at the NIH booth! This is an incredible opportunity to further highlight Pirouette’s patented autoinjector technology. We are grateful for the support and partnership of the NIH SEED in our journey to make life-saving injections as easy as pushing a button. Let’s make a difference together! #BIO2024 #MedTech #NIH

I’m proud to share that Pirouette has been invited to participate in the Food Allergy Fund Summit on May 23 in New York City! I'll be joining other industry leaders for a panel discussion on emerging solutions in the field where we’ll highlight our Epinephrine auto-injector. 📅 Date: Thursday, May 23 📍 Location: Paley Center for Media, NYC. 👥 Event: Panel on innovative food allergy solutions ft. Pirouette If you're in the area, we'd love for you to join us! Please follow the link in the comments below to register to attend. Hope to see you there!

We’re honored to be recognized as an NIH SEED Innovation Company! Pirouette was selected out of hundreds of companies to represent the NIH at BIO 2024, underscoring our dedication to healthcare advancement. It is so exciting to be recognized as one of the top companies with NIH support. This is a fantastic platform to demonstrate how we're transforming the future of injections, especially when it comes to addressing the opioid overdose epidemic. We look forward to presenting and connecting with industry leaders. ⚕️ Thank you to the NIH for your continued support! #BIO2024 #MedTech #NIH

Big news at Pirouette! 🚀 VentureBeat, a top platform for the latest in tech and venture capital news, picked up our $5M+ raise! To date, we’ve successfully raised over $5 million from nearly 800 visionary investors, and we're not slowing down! We can't wait to present at KingsCrowd's exclusive Demo Day next week and showcase our groundbreaking advancements for life-saving injections at next month’s renowned BIO conference alongside the NIH. 🧬 If you've been thinking about investing or upping your stake, NOW is the time before the round fills up! Invest or increase your investment today → https://lnkd.in/gtT4-Z7V ⏳ Safar Partners

Due to popular demand, Pirouette has received a special invitation to participate in KINGSCROWD’s Spring 2024 Demo Day. KingsCrowd investors who missed our Startup Showcase pitch in Chicago will have another opportunity to see us present at the upcoming Demo Day. 🥳 KingsCrowd, recognized as the #1 independent ratings and analytics platform for online private markets, also recently invested in Pirouette. We’re honored to be included in this prestigious event. 🚀 Details below: 📆 When: Thursday, May 16th at 12 PM ET / 9 AM PT ♟️ Who: The KingsCrowd Team and Pirouette 💫 What: Live founder pitches, interactive Q&A, and a roundtable discussion with the KingsCrowd team 📍Where: Link in comments Following the pitches, the KingsCrowd team will provide a detailed analysis of each founder’s presentation and even crown a winner for the best pitch of the day! You don’t want to miss this!🏆